Drug Type TCR-T Cell therapy |
Synonyms AFP TCR-T, Alpha fetoprotein T Cell Receptor, C TCR055 + [3] |
Target |
Action inhibitors |
Mechanism AFP inhibitors(Alpha-fetoprotein inhibitors), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatocellular Carcinoma | Phase 1 | China | 06 Aug 2019 |





